United Kingdom· GB-APID-34848611000001105
Symtuza 800mg/150mg/200mg/10mg tablets
A emtricitabine, tenofovir alafenamide, darunavir and cobicistat product containing darunavir + cobicistat + emtricitabine + tenofovir alafenamide, registered in United Kingdom by Janssen-Cilag Ltd. The same ATC class is registered in 12 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Emtricitabine, tenofovir alafenamide, darunavir and cobicistat is registered in 12 of 19 countries.
Countries holding a registration under ATC J05AR22 (emtricitabine, tenofovir alafenamide, darunavir and cobicistat), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Emtricitabine, tenofovir alafenamide, darunavir and cobicistat · ATC J05AR22
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Darunavir + Cobicistat + Emtricitabine + Tenofovir alafenamide
- Manufacturer
- Janssen-Cilag Ltd
- Country
- United Kingdom (GB)
- ATC code
- J05AR22
- ATC class
- Emtricitabine, tenofovir alafenamide, darunavir and cobicistat
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 4
- gtin5012674903063
- gtin05012674903063
- gtin5012674903544
- gtin05012674903544
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Emtricitabine, tenofovir alafenamide, darunavir and cobicistat in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainSYMTUZA 800 MG/150 MG/200 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULAJanssen-Cilag International N.V
- CanadaSYMTUZAJANSSEN INC
- SwitzerlandSymtuza, FilmtablettenJanssen-Cilag AG
- PolandSymtuzaJanssen-Cilag International N.V.
- United StatesSymtuzaJanssen Products LP
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Symtuza
- Liechtenstein · Symtuza
- Norway · Symtuza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f38da513-a9b6-49c8-9cf5-30e71e744312 GET /v1/drugs/f38da513-a9b6-49c8-9cf5-30e71e744312?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "34848611000001105",
"desc": "Symtuza 800mg/150mg/200mg/10mg tablets (Janssen-Cilag Ltd)",
"form": "Oral tablet",
"vpid": "34878311000001101",
"source": "dmd",
"vtm_id": "34879511000001101",
"strength": "10 mg",
"substance": "Darunavir + Cobicistat + Emtricitabine + Tenofovir alafenamide",
"ingredient": "Tenofovir alafenamide fumarate",
"supplier_code": "2422501000001106"
}See everything about emtricitabine, tenofovir alafenamide, darunavir and cobicistat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.